miR-195の発現抑制は、BCL2L2を標的とすることによる酸素-グルコース脱離/再灌流誘発性のBBB破壊を減弱させる

Mingyan Dong1, Lihui Huang1, Qiaohong Zhang1

  • 1National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.

Frontiers in neuroscience
|February 26, 2026
PubMed
要旨